An increased prevalence of nephrolithiasis has been reported in patients with diabetes. Because insulin resistance, characteristic of the metabolic syndrome and type 2 diabetes, results in lower urine pH through impaired kidney ammoniagenesis and because a low urine pH is the main factor of uric acid (UA) stone formation, it was hypothesized that type 2 diabetes should favor the formation of UA stones. Therefore, the distribution of the main stone components was analyzed in a series of 2464 calculi from 272 (11%) patients with type 2 diabetes and 2192 without type 2 diabetes. The proportion of UA stones was 35.7% in patients with type 2 diabetes and 11.3% in patients without type 2 diabetes (P < 0.0001). Reciprocally, the proportion of patients with type 2 diabetes was significantly higher among UA than among calcium stone formers (27.8 versus 6.9%; P < 0.0001). Stepwise regression analysis identified type 2 diabetes as the strongest factor that was independently associated with the risk for UA stones (odds ratio 6.9; 95% confidence interval 5.5 to 8.8). The proper influence of type 2 diabetes was the most apparent in women and in patients in the lowest age and body mass index classes. In conclusion, in view of the strong association between type 2 diabetes and UA stone formation, it is proposed that UA nephrolithiasis may be added to the conditions that potentially are associated with insulin resistance. Accordingly, it is suggested that patients with UA stones, especially if overweight, should be screened for the presence of type 2 diabetes or components of the metabolic syndrome.
机构:
Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R ChinaTianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China
Ren, Yanfeng
Ji, Linong
论文数: 0引用数: 0
h-index: 0
机构:
Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing, Peoples R ChinaTianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China
Ji, Linong
Mu, Yiming
论文数: 0引用数: 0
h-index: 0
机构:
Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R ChinaTianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China
Mu, Yiming
Hong, Tianpei
论文数: 0引用数: 0
h-index: 0
机构:
Peking Univ, Hosp 3, Dept Endocrinol, 49 Huayuanbei Rd, Beijing 100191, Peoples R ChinaTianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China
Hong, Tianpei
Ji, Qiuhe
论文数: 0引用数: 0
h-index: 0
机构:
Fourth Mil Med Univ, Xi Jing Hosp, Dept Endocrinol, Xian, Peoples R ChinaTianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China
Ji, Qiuhe
Guo, Lixin
论文数: 0引用数: 0
h-index: 0
机构:
Beijing Hosp, Dept Endocrinol, Beijing, Peoples R ChinaTianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China
Guo, Lixin
Huang, Qin
论文数: 0引用数: 0
h-index: 0
机构:
Changhai Hosp Shanghai, Dept Endocrinol, Shanghai, Peoples R ChinaTianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China
Huang, Qin
Yang, Xilin
论文数: 0引用数: 0
h-index: 0
机构:
Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R ChinaTianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China
机构:
Litholink Corp, Lab Corp Amer Holdings, Chicago, IL USALitholink Corp, Lab Corp Amer Holdings, Chicago, IL USA
Asplin, John R.
Goldfarb, David S.
论文数: 0引用数: 0
h-index: 0
机构:
VA New York Harbor Healthcare Syst, Nephrol Sect, New York, NY USA
NYU, Sch Med, Nephrol Div, New York, NY USALitholink Corp, Lab Corp Amer Holdings, Chicago, IL USA